Table 2 Clinical outcomes following initial visit for liver transplant evaluation. Values are shown as median (interquartile range) or number (percentage) unless otherwise described
On NSBB n = 65 | Not on NSBB n = 105 | P value | |
|---|---|---|---|
Liver transplant selection committee discussion | 40 (62%) | 56 (53%) | |
List | 26 (40%) | 34 (32%) | NS |
Undetermined | 7 (11%) | 10 (10%) | |
Denied | 7 (11%) | 12 (19%) | |
Duration of follow up (months) | 31 (8–64) | 23.4 (6–63) | NS |
Hospitalized within 90 days | 18 (28%) | 23 (23%) | NS |
Number of hospitalizations | 1 (0–3) (mean 2.2 ± 2.6) | 1 (0–2) (mean 1.3 ± 1.6) | .06 |
Acute kidney injury | |||
Overall | 28 (43%) | 22 (20%) | .002 |
Stage 1 | 14 (50%) | 2 (10%) | .009 |
Stage2 | 5 (18%) | 7 (32%) | |
Stage 3 | 9 (32%) | 13 (59%) | |
90-day | 14 (22%) | 11 (11%) | .048 |
Stage 1 | 5 (36%)b | 1 (9%)b | NS |
Stage2 | 3 (21%) | 4 (36%) | |
Stage 3 | 6 (43%) | 6 (55%) | |
Gastrointestinal bleedinga | |||
Overall | 10 (15%) | 9 (9%) | NS |
90-day | None | None | |
Spontaneous bacterial peritonitis | |||
Overall | 9 (14%) | 6 (6%) | 0.09 |
90-day | 4 (6%) | 2 (2%) | NS |
Liver transplant | |||
Overall | 21 (33%) | 32 (31%) | NS |
90-day | 1 (2%) | 5 (5%) | |
Mortality | |||
Overall | 32 (49%) | 45 (43%) | NS |
90-day | 4 (6%) | 16 (15%) | .06 |